The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Murray Mark J. since 2015.
The trader's CIK number is 1628383.
At the time of the last reporting, Murray Mark J. was the President & CEO of Arbutus Biopharma Corp. (stock ticker symbol ABUS).
Also see all insider trading activities at Arbutus Biopharma Corp.
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2018 | ABUS | 0 | $0 | 0 | $0 | 52,007 | $43,310 |
| 2015 | ABUS | 0 | $0 | 0 | $0 | 219,428 | $97,426 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2018-11-28 | ABUS | Option Ex | 25,000 | 1.35 | 33,750 |
| 2018-04-17 | ABUS | Option Ex | 27,007 | .35 | 9,560 |
| 2015-09-11 | TKMR | Option Ex | 219,428 | .44 | 97,426 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Murray Mark J. (President & CEO of Arbutus Biopharma Corp at the time of this reporting) see the Securities and Exchange Commission (SEC) website.